Description: Session 4B: Impact of GLP-1 Drugs on Health Care Cost Trend and Clinical Outcomes

Description: Session 6B: Unraveling the Mysteries of Cell & Gene Therapy Eligibility and Demand

Description: Session 9A: Medicaid Continuous Coverage Unwinding - A Risk Mitigation Case Study

Description: Session 10D: Medicare Advantage - Limit it or Use it to Replace Medicare + MedSupp?

Description: Virtual - Session 4A: Data Science-Driven MA Product Design Strategies

Description: Virtual - Session 8A: Diagnostics in Focus - Innovations, Challenges and Actuarial Perspectives

Description: Discuss changes in group life waiver of premium claim recovery and mortality experience since the 2005 table was released, the development of the 2023 table, and the new statutory valuation standard approved by the National Association of Insurance Commissioners (NAIC).

Description: It's your first full day of productive learning! Start it off right with a delicious breakfast and warm welcome.

Description: Attendees will hear examples of individuals with medical conditions which are either being treated by gene therapy or have gene therapy treatments in development. Attendees will learn about what gene therapy is, current development methods, treatment efficacy, and expectations for future gene therapy treatments. We will explore funding challenges for gene therapy and potential methods to manage costs for gene therapy treatments.

Description: Value-based care models have to date been focused on either broad, total-cost-of-care, primary care-based models; or on a limited set of episodes of care. This session will focus on initiatives to bring these concepts together for improved outcomes for patients and greater savings from an integrated solution.